Cargando…
Potential biomarkers of immune protection in human leishmaniasis
Leishmaniasis is a vector-borne neglected tropical disease endemic in over 100 countries around the world. Available control measures are not always successful, therapeutic options are limited, and there is no vaccine available against human leishmaniasis, although several candidate antigens have be...
Autores principales: | Rostami, Mahmoud Nateghi, Khamesipour, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088758/ https://www.ncbi.nlm.nih.gov/pubmed/33934238 http://dx.doi.org/10.1007/s00430-021-00703-8 |
Ejemplares similares
-
Immune response in cutaneous leishmaniasis patients with healing vs. non-healing lesions
por: Miramin-Mohammadi, Akram, et al.
Publicado: (2020) -
CD8(+) T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis
por: Nateghi Rostami, Mahmoud, et al.
Publicado: (2010) -
Immune Responses in Cutaneous Leishmaniasis: In vitro Thelper1/Thelper2 Cytokine Profiles Using Live Versus Killed Leishmania major
por: Miramin-Mohammadi, Akram, et al.
Publicado: (2021) -
Comparative evaluation of salivary glands proteomes from wild Phlebotomus papatasi
–proven vector of zoonotic cutaneous leishmaniasis in Iran
por: Maryam Ghafari, Seyedeh, et al.
Publicado: (2020) -
The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2016)